TransMedics Group Stock Trades on Nasdaq Amid Institutional Shifts
What happened
TransMedics Group, Inc. filed disclosures with the Securities and Exchange Commission and began trading on Nasdaq. During the third quarter, Zevenbergen Capital Investments LLC reduced its position in the company by 13.3% after selling 41,109 shares. The company's stock traded down $2.07 on Thursday, reaching $79.00.
From tickerreport.com
Why it matters
The listing on Nasdaq and the filings with the Securities and Exchange Commission highlight the company's public market status. Institutional investors currently own 99.67% of TransMedics Group stock, with several funds making recent changes to their holdings.
From tickerreport.com
Who's involved
- David WeillDirector who purchased company stock
- Securities and Exchange CommissionGovernment agency that received company disclosures
- NasdaqStock exchange where TransMedics Group trades
Who could feel it
Possible knock-on effectsThese are possibilities Brind reasoned out, not predictions, and not advice. Most are not stated in any report.
- David WeillSpeculative
Director David Weill might see his personal stake increase due to the purchase of 1,336 shares.
Keep exploring
The entities involved
-
Securities and Exchange Commission
government agency of the Philippines
-
Nasdaq
American fully electronic stock exchange
Related events
- Shake Shack filed disclosures with the Securities and Exchange Commission.
- Viasat files disclosures with the SEC and its stock trades on the Nasdaq exchange on August 5, 2026.
- Range Resources Corporation filed disclosures with the Securities and Exchange Commission on August 31, 2026.
- NewJersey Resources Corporation filed disclosures with the Securities and Exchange Commission on July 28, 2026.
- Encompass Health filed disclosures with the Securities and Exchange Commission on September 19, 2026.